Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration.

[1]  K. Zahs,et al.  Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile , 2015, PloS one.

[2]  Nikolaos G Sgourakis,et al.  Modeling an in-register, parallel "iowa" aβ fibril structure using solid-state NMR data from labeled samples with rosetta. , 2015, Structure.

[3]  J. Cirrito,et al.  Genetic Modulation of Soluble Aβ Rescues Cognitive and Synaptic Impairment in a Mouse Model of Alzheimer's Disease , 2014, The Journal of Neuroscience.

[4]  Charles D. Schwieters,et al.  Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue , 2013, Cell.

[5]  Val Lowe,et al.  Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. , 2013, Brain : a journal of neurology.

[6]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[7]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[8]  A. Abdipranoto,et al.  Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease , 2013, PloS one.

[9]  D. Eisenberg,et al.  Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates , 2012, Proceedings of the National Academy of Sciences.

[10]  David Eisenberg,et al.  Atomic View of a Toxic Amyloid Small Oligomer , 2012, Science.

[11]  Mark P Mattson,et al.  Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils , 2012, Proceedings of the National Academy of Sciences.

[12]  F. Barkhof,et al.  Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. , 2012, Archives of neurology.

[13]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[14]  K. Ashe,et al.  Cognitive effects of cell-derived and synthetically derived Aβ oligomers , 2011, Neurobiology of Aging.

[15]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[16]  R. Kayed,et al.  Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain*♦ , 2011, The Journal of Biological Chemistry.

[17]  R. Tycko.  Solid-state NMR studies of amyloid fibril structure. , 2011, Annual review of physical chemistry.

[18]  Nick C Fox,et al.  11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study , 2010, The Lancet Neurology.

[19]  C. Glabe.  Amyloid Oligomer Structures and Toxicity~!2009-04-30~!2009-07-07~!2010-01-02~! , 2010 .

[20]  C. Glabe.  Amyloid Oligomer Structures and Toxicity , 2009 .

[21]  L. Breydo,et al.  Fibrillar Oligomers Nucleate the Oligomerization of Monomeric Amyloid β but Do Not Seed Fibril Formation* , 2009, The Journal of Biological Chemistry.

[22]  D. Selkoe,et al.  Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life , 2009, Neurobiology of Disease.

[23]  K. Imahori,et al.  Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease Brains* , 2009, The Journal of Biological Chemistry.

[24]  B. Hyman,et al.  A single dose of passive immunotherapy has extended benefits on synapses and neurites in an Alzheimer's disease mouse model , 2009, Brain Research.

[25]  C. Glabe,et al.  Structural Classification of Toxic Amyloid Oligomers* , 2008, Journal of Biological Chemistry.

[26]  K. Ashe,et al.  Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. , 2008, The American journal of pathology.

[27]  F. Haiss,et al.  Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance , 2008, The Journal of Neuroscience.

[28]  R. A. Wallis,et al.  Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. , 2008, Brain : a journal of neurology.

[29]  K. Ashe,et al.  Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function , 2008, Neuroscience.

[30]  C. Cotman,et al.  Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers , 2007, Molecular Neurodegeneration.

[31]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[32]  J. D. McGaugh,et al.  Learning Decreases Aβ*56 and Tau Pathology and Ameliorates Behavioral Decline in 3xTg-AD Mice , 2007, The Journal of Neuroscience.

[33]  M. Richard.  Theories of Hippocampal Function , 2006 .

[34]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[35]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[36]  H. Lester,et al.  Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease , 2005, PLoS medicine.

[37]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[38]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[39]  George A. Carlson,et al.  The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[40]  Mikio Shoji,et al.  Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.

[41]  R. Elliott,et al.  Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. , 1998, Neurotoxicology and teratology.

[42]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[43]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[44]  F. Vanhaaren,et al.  Acquisition of conditional associations and operant delayed spatial response alternation: effects of lesions in the medial prefrontal cortex. , 1988 .

[45]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[46]  C. Schwieters,et al.  Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue. , 2013 .

[47]  K. Zahs,et al.  Grape seed polyphenolic extract specifically decreases aβ*56 in the brains of Tg2576 mice. , 2011, Journal of Alzheimer's disease : JAD.

[48]  Kimberly Scearce-Levie,et al.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. , 2007, The Journal of biological chemistry.

[49]  J. Trojanowski,et al.  Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. , 2006, The Journal of biological chemistry.

[50]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[51]  David M Holtzman,et al.  Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. , 2005, Neuron.

[52]  S. Younkin,et al.  The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  C. V. van Eden,et al.  Acquisition of conditional associations and operant delayed spatial response alternation: effects of lesions in the medial prefrontal cortex. , 1988, Behavioral neuroscience.